Electromagnetic Field Effects of Mobile Communication (LTE) on Sleep in the Context of Genetic Variation

January 27, 2023 updated by: University of Zurich
The effect of electromagnetic fields of the latest standard in mobile communication (long term evolution, LTE) on sleep is studied in healthy, young individuals.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland, 8057
        • University of Zurich, Institute of Pharmacology and Toxicology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Age 18-30 years
  • German knowledge (reading and writing)
  • Right-handedness
  • Body mass index (BMI) 18.5-25.0 kg/m2
  • Mobile communication (phone calls) less than 2 hours per week
  • Moderate alcohol consumption (less than 5 alcoholic beverages per week)
  • Moderate caffeine consumption (less than 5 caffeinated foods per day, e.g. coke, coffee, energy drinks, green or black tea, chocolate)
  • Informed consent

Exclusion Criteria:

  • Travels across more than 2 time zones in the last 30 days or during the study
  • Nocturnal shift work
  • Extreme chronotype or extreme sleep duration (less than 5 hours or more than 10 hours on average)
  • Sleep disorders or problems
  • Severe acute or chronic neurological, mental or general health disorders, which might impair the participant's safety or affect the study's outcome
  • Use of medication (regular or during the study), which might affect the study's outcome
  • Recreational drug use
  • Smoking (or other tobacco products)
  • Severe skin allergies
  • Relevant findings in physical examination or during the screening night (e.g. sleep disorders)
  • Participation in an other clinical trial in the last 30 days or during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: LTE field
electromagnetic field of the latest standard in mobile communication (long term evolution, LTE)
Sham Comparator: sham field
no electromagnetic field

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
electroencephalographic power during sleep after LTE exposure
Time Frame: up to 9 hours (approximately 11 p.m. to 8 a.m.)
electroencephalogram (EEG)
up to 9 hours (approximately 11 p.m. to 8 a.m.)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hans-Peter Landolt, University of Zurich, Institute of Pharmacology and Toxicology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2017

Primary Completion (Actual)

September 30, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

February 23, 2017

First Submitted That Met QC Criteria

March 3, 2017

First Posted (Actual)

March 9, 2017

Study Record Updates

Last Update Posted (Estimate)

January 30, 2023

Last Update Submitted That Met QC Criteria

January 27, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • LTE-Sleep

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep

Clinical Trials on LTE field

3
Subscribe